Thursday, 3 August 2017

Development of Cardiac Maker Analyzer Product : Overview, Size and Share 2017

ResearchMoz presents professional and in-depth study of "Cardiac Maker Analyzer Product Analysis, Business & Marketing Strategy of Cardiac Maker Companies".

Cardiometabolic products and services provide timely cardiovascular and metabolic information at the point-of-care. Until today, Troponin and CK-MB were the lead cardiac markers. Brain Natriuetic Pepetide (BNP) was recently introduced to differentiate between a Myocardial Infarction and Heart Failure. The routine markers of myocardial infarction – CK-MB, Troponin and Myoglobin and recently BNP are used in the acute care and tests such as Cholesterol are used to evaluate risk. A number of companies are focused on developing new cardiac markers.

Alere delivers reliable and actionable health information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Alere’s Cardiology net product sale was more than US$ 600 Million in 2016 and is expected to rule this industry in the future.

Beckman Coulter offers the maximum number of cardiac marker tests on its cardiology platform while Abbott Laboratories (i-Stat) and Siemens Healthineers (Stratus® CS Analyzer) also perform several cardiac marker tests on their cardio-metabolism platform and establishes them as the leader in this market.

Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged.  Physicians use cardiac markers in two ways – to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.

Get PDF for more Professional and Technical insights @

Cardiac Maker Analyzer – Product Analysis, Business & Marketing Strategy of Cardiac Maker Companies is the 2nd report published by Renub Research. This 105 page report contains 14 Figures and 12 Tables provides a comprehensive analysis of the cardiac markers analyzer segments, including their comparative tests analysis, competitive product analysis, product features, merger, acquisitions, analyzer sales figures and Business and Market Strategies of Companies.

All the 12 Cardiac Marker Analyzers in the report have been studied from 5 viewpoints.

    Analyzer Specifications and Benefits
    Net Product Sales
    Merger, Acquisition & Licensing Agreement
    Marketing Strategies
    Methods of Distribution

Table of Content

1. Executive Summary

2. Cardiac Marker Companies – Comparative Tests Analysis

3. Cardiac Marker Analyzer – Competitive Product Analysis

Make an Enquiry about TOC @

4. Alere
4.1 Alere Triage
4.1.1 Triage MeterPro Analyzer
4.2 Alere Cardiology Net Sales & Forecast (2011 - 2022)

5. Response Biomedical
5.1 Cardiovascular Testing
5.1.1 Acute Myocardial Infarction (Heart Attack) Testing
5.1.2 Congestive Heart Failure (“CHF”) Testing
5.1.3 Thrombotic Disease Testing
5.2 RAMP Platform
5.2.1 RAMP 200
5.2.2 RAMP Reader
5.3 Response Biomedical Cardiovascular Net Sales (2011 – 2022)

6. Abbott Point of Care
6.1 The i–STAT System
6.2 Abbott Laboratories Point of Care Diagnostics Sales (2011 – 2022)

7. Roche
7.1 Cobas h 232 POC System

8. Siemens Healthineers
8.1 Stratus CS Analyzer
8.2 Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare

9. Beckman Coulter
9.1 Access 2 Immunoassay System

10. Boditech
10.1 i–chroma DUO Analyzer

Browse Full Report @

11. Lifesign
11.1 DXpress Reader Analyzer

12. LSI Medience Corporation
12.1 PATHFAST Analyzer

For More Information Kindly Contact:

Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Follow us on LinkedIn @
Follow me on :

No comments:

Post a Comment